Although the role of ACE2 in hypertension is clear, the underlying mechanism needs to be elucidated to identify the relevant downstream signalling pathways and clinical trials need to be designed to determine whether up‐regulating the ACE2 level can lower blood pressure in patients. The gene discussed is ACE2; the disease is Hypertension.